by pneumatic dilation. Gastroenterology 1992; 103:1732–1738.
142 142 Achem SR, Gerson LB. Distal esophageal spasm: An update. Curr Gastroenterol Rep 2013; 15:7–15.
143 143 Pandolfino JE, Roman S, Carlson D, et al. Distal esophageal spasm in high‐resolution esophageal pressure topography: defining clinical phenotypes. Gastroenterology 2011; 141:469–475.
144 144 Konturek JW, Gillessen A, Domschke W. Diffuse esophageal spasm: a malfunction that involves nitric oxide? Scand J Gastroenterol 1995; 30:1041–1045.
145 145 Murray JA, Ledlow A, Launspach J, et al. The effects of recombinant human hemoglobin on esophageal motor function in humans. Gastroenterology 1995; 109:1241–1248.
146 146 Samo S, Carlson DA, Kahrilas PJ, et al. Ineffective esophageal motility progressing into distal esophageal spasm and then type III achalasia. ACG Case Reports J 2016; 3:e183.
147 147 De Schepper HU, Smout AJPM, Bredenoord AJ. Distal esophageal spasm evolving to achalasia in high resolution. Clin Gastroenterol Hepatol 2014; 12:A25–A26.
148 148 Jia Y, Arenas J, Hejazi RA, et al. Frequency of jackhammer esophagus as the extreme phenotype of esophageal hypercontractility based on the new Chicago Classification. J Clin Gastroenterol 2016; 50:615–618.
149 149 Roman S, Pandolfino JE, Chen J, et al. Phenotypes and clinical context of hypercontractility in high‐resolution esophageal pressure topography (EPT). Am J Gastroenterol 2012; 107:37–45.
150 150 Loo FD, Dodds WJ, Soergel KH, et al. Multipeaked esophageal peristaltic pressure waves in patients with diabetic neuropathy. Gastroenterology 1985; 88:485–491.
151 151 Jung H‐Y, Puckett JL, Bhalla V, et al. Asynchrony between the circular and thelongitudinal muscle contraction in patients with Nutcracker Esophagus. Gastroenterology 2005; 128:1179–1186.
152 152 Richter JE, Dalton CB, Bradley LA, et al. Oral nifedipine in the treatment of noncardiac chest pain in patients with the nutcracker esophagus. Gastroenterology 1987; 93:21–28.
153 153 Cattau EL, Castell DO, Johnson DA, et al. Diltiazem therapy for symptoms associated with nutcracker esophagus. Am J Gastroenterol 1991; 86:272–276.
154 154 Traube M. Effects of nifedipine in achalasia and in patients with high‐amplitude peristaltic esophageal contractions. JAMA 1984; 252:1733.
155 155 Drenth J, Bos L, Engels L. Efficacy of diltiazem in the treatment of diffuse oesophageal spasm. Aliment Pharmacol Ther 1990; 4:411–416.
156 156 Davies A, Lewis MJ, Rhodes J, et al. Trial of Nifedipine for prevention of oesophageal spasm. Digestion 1987; 36:81–83.
157 157 Swamy N. Esophageal spasm: clinical and manometric response to nitroglycerine and long acting nitrites. Gastroenterology 1977; 72:23–27.
158 158 Orlando RC, Bozymski EM. Clinical and manometric effects of nitroglycerin in diffuse esophageal spasm. N Engl J Med 1973; 289:23–25.
159 159 Wen Z, Gardener E, Wang Y. Nitrates for achalasia. Cochrane Database Syst Rev 2004; 1:CD002299.
160 160 Roman S, Kahrilas PJ. Management of spastic disorders of the esophagus. Gastroenterol Clin North Am 2013; 42:27–43.
161 161 Bortolotti M, Mari C, Lopilato C, et al. Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology 2000; 118:253–257.
162 162 Eherer AJ. Effect of sildenafil on oesophageal motor function in healthy subjects and patients with oesophageal motor disorders. Gut 2002; 50:758–764.
163 163 Pimentel M, Bonorris GG, Chow EJ, et al. Peppermint oil improves the manometric findings in diffuse esophageal spasm. J Clin Gastroenterol 2001; 33:27–31.
164 164 Khalaf MHG, Chowdhary S, Elmunzer BJ, et al. Impact of peppermint therapy on dysphagia and non‐cardiac chest pain: A Pilot Study. Dig Dis Sci 2019; 64(8):2414–18.
165 165 Pandolfino JE, Kwiatek MA, Nealis T, et al. Achalasia: a new clinically relevant classification by high‐resolution manometry. Gastroenterology 2008; 135:1526–1533.
166 166 Ebert EC, Ouyang A, Wright SH, et al. Pneumatic dilatation in patients with symptomatic diffuse esophageal spasm and lower esophageal sphincter dysfunction. Dig Dis Sci 1983; 28:481–485.
167 167 Pasricha P, Rai R, Ravich W, et al. Botulinum toxin for achalasia: Long‐term outcome and predictors of response. Gastroenterology 1996; 110:1410–1415.
168 168 Cuilliere C, Ducrotte P, Zerbib F, et al. Achalasia: outcome of patients treated with intrasphincteric injection of botulinum toxin. Gut 1997; 41:87–92.
169 169 Shaheen NJ, Falk GW, Iyer PG, et al. ACG clinical guideline: diagnosis and management of Barrett’s esophagus. Am J Gastroenterol 2016; 111:30–50.
170 170 Fishman V, Parkman H, Schiano T, et al. Symptomatic improvement in achalasia after botulinum toxin injection of the lower esophageal sphincter. Am J Gastroenterol 1996; 91:1724–1730.
171 171 Storr M, Allescher H‐D, Rösch T, et al. Treatment of symptomatic diffuse esophageal spasm by endoscopic injections of botulinum toxin: A prospective study with long‐term follow‐up. Gastrointest Endosc 2001; 54:754–759.
172 172 Wang L, Li Y‐M, Li L. Meta‐Analysis of randomized and controlled treatment trials for achalasia. Dig Dis Sci 2009; 54:2303–2311.
173 173 Yaghoobi M, Mayrand S, Martel M, et al. Laparoscopic Heller’s myotomy versus pneumatic dilation in the treatment of idiopathic achalasia: a meta‐analysis of randomized, controlled trials. Gastrointest Endosc 2013; 78:468–475.
174 174 Boeckxstaens GE, Annese V, Varannes SB des, et al. Pneumatic dilation versus laparoscopic Heller myotomy for idiopathic achalasia. N Engl J Med 2011; 364:1807–1816.
175 175 Yuan X‐L, Liu W, Ye L‐S, et al. Peroral endoscopic dual myotomy (dual POEM) for achalasia with severe esophageal dilatation. Endoscopy 2018; 50:E179–E180.
176 176 Kumbhari V, Tieu A, Onimaru M, et al. Peroral endoscopic myotomy (POEM) vs laparoscopic Heller myotomy (LHM) for the treatment of Type III achalasia in 75 patients: a multicenter comparative study. Endosc Int Open 2015; 3:E195–E201.
177 177 Khashab MA, Benias PC, Swanstrom LL. Endoscopic myotomy for foregut motility disorders. Gastroenterology 2018; 154:1901–1910.
178 178 Ujiki MB, Yetasook AK, Zapf M, et al. Peroral endoscopic myotomy: A short‐term comparison with the standard laparoscopic approach. Surgery 2013; 154:893–900.
179 179 Youn YH, Minami H, Chiu PWY, et al. Peroral endoscopic myotomy for treating achalasia and esophageal motility disorders. J Neurogastroenterol Motil 2015; 22:14–24.
180 180 Shiwaku H, Inoue H, Beppu R, et al. Successful treatment of diffuse esophageal spasm by peroral endoscopic myotomy. Gastrointest Endosc 2013; 77:149–150.
181 181 Albers D, Frieling T, Dakkak D, et al. Peroral endoscopic myotomy (POEM) is effective in treatment of noncardiac chest pain caused by hypercontractile esophageal motility disorders: results of the POEM‐HYPE‐Study. Z Gastroenterol 2018; 56:1337–1342.
182 182 Filicori F, Dunst CM, Sharata A, et al. Long‐term outcomes following POEM for non‐achalasia motility disorders of the esophagus. Surg Endosc Other Interv Tech 2018; 0:0.
183 183 Khan MA, Kumbhari V, Ngamruengphong S, et al. Is POEM the answer for management of spastic esophageal disorders? a systematic review and meta‐analysis. Dig Dis Sci 2017; 62:35–44.
184 184 Ponds FA, Fockens P, Lei A, et al. Effect of peroral endoscopic myotomy vs pneumatic dilation on symptom severity and treatment outcomes among treatment‐naive patients with achalasia. JAMA 2019; 322:134.
185 185 Kumbhari V, Familiari P, Bjerregaard N, et al. Gastroesophageal reflux after peroral endoscopic myotomy: a multicenter case‐control study. Endoscopy 2017; 49:634–642.
186 186 Schlottmann F, Luckett DJ, Fine J, et al. Laparoscopic Heller myotomy versus peroral endoscopic myotomy (POEM) for achalasia. Ann Surg 2018; 267:451–460.
187 187